Biomarkers of Bipolar Disorder in Late Life: An Evidence-Based Systematic Review

被引:4
|
作者
Chancel, R. [1 ,2 ]
Lopez-Castroman, J. [3 ,4 ,5 ,6 ]
Baca-Garcia, E. [7 ,8 ,9 ,10 ,11 ,12 ,13 ,14 ]
Alvarez, R. Mateos [15 ,16 ]
Courtet, Ph. [1 ,2 ]
Conejero, I. [7 ,9 ,10 ,17 ,18 ]
机构
[1] Univ Montpellier, PSNREC, INSERM, CHU Montpellier, Montpellier, France
[2] CHU Montpellier, Lapeyronie Hosp, Dept Emergency Psychiat & Acute Care, Montpellier, France
[3] Nimes Univ Hosp, Dept Psychiat, Nimes, France
[4] Carlos III Univ, Dept Signal Theory & Commun, Madrid, Spain
[5] Univ Montpellier, Inst Genom Fonct, CNRS, INSERM, Montpellier, France
[6] Ctr Invest Biomed Red Salud Mental, Madrid, Spain
[7] Fdn Jimenez Diaz, Inst Invest Sanitaria, Madrid, Spain
[8] Hosp Univ Rey Juan Carlos, Dept Cirugia, Mostoles, Madrid, Spain
[9] Univ Autonoma Madrid, Madrid, Spain
[10] Hosp Univ Fdn Jimenez Diaz, Dept Psychiat, Madrid, Spain
[11] Hosp Univ Cent Villalba, Dept Psychiat, Madrid, Spain
[12] Hosp Univ Infanta Elena, Dept Psychiat, Madrid, Spain
[13] Univ Catolica Maude, Talca, Chile
[14] Inst Salud Carlos III, CIBERSAM, Madrid, Spain
[15] Univ Santiago de Compostela, Dept Psychiat, Santiago De Compostela, Spain
[16] CHUS Univ Hosp, Psychogeriatr Unit, Santiago De Compostela, Spain
[17] Univ Montpellier, Dept Psychiat, CHU Nimes, PSNREC,INSERM, Nimes, France
[18] Pole Psychiat, CHU Nimes, Rue Prof Robert Debre, F-30900 Nimes, France
关键词
Mood disorder; Older adults; Biological factors; Late-onset bipolar disorder; AGE-OF-ONSET; NEUROFILAMENT LIGHT-CHAIN; DSM-IV DISORDERS; GRAY-MATTER; SCHIZOPHRENIA; EXPRESSION; ASSOCIATION; DEPRESSION; INFLAMMATION; AUGMENTATION;
D O I
10.1007/s11920-024-01483-7
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Purpose of ReviewReview the current evidence on biomarkers for bipolar disorder in the older adults. We conducted a systematic search of PubMed MEDLINE, PsycINFO, and Web of Science databases using the MeSH search terms "Biomarkers", "Bipolar Disorder", "Aged" and and "Aged, 80 and over". Studies were included if they met the following criteria: (1) the mean age of the study population was 50 years old or older, (2) the study included patients with bipolar disorder, and (3) the study examined one type of biomarkers or more including genetic, neuroimaging, and biochemical biomarkers. Reviews, case reports, studies not in English and studies for which no full text was available were excluded. A total of 26 papers were included in the final analysis.Recent FindingsGenomic markers of bipolar disorder in older adults highlighted the implication of serotonin metabolism, while the expression of genes involved in angiogenesis was dysregulated. Peripheral blood markers were mainly related with low grade inflammation, axonal damage, endothelial dysfunction, and the dysregulation of the HPA axis. Neuroanatomical markers reflected a dysfunction of the frontal cortex, a loss of neurones in the anterior cingulate cortex and a reduction of the hippocampal volume (in patients older than 50 years old). While not necessarily limited to older adults, some of them may be useful for differential diagnosis (neurofilaments), disease staging (homocysteine, BDNF) and the monitoring of treatment outcomes (matrix metalloproteinases).SummaryOur review provides a comprehensive overview of the current evidence on biomarkers for bipolar disorder in the older adults. The identification of biomarkers may aid in the diagnosis, treatment selection, and monitoring of bipolar disorder in older adults, ultimately leading to improved outcomes for this population. Further research is needed to validate and further explore the potential clinical utility of biomarkers in this population.
引用
收藏
页码:78 / 103
页数:26
相关论文
共 50 条
  • [1] Biomarkers of Bipolar Disorder in Late Life: An Evidence-Based Systematic Review
    R. Chancel
    J. Lopez-Castroman
    E. Baca-Garcia
    R. Mateos Alvarez
    Ph. Courtet
    I. Conejero
    Current Psychiatry Reports, 2024, 26 : 78 - 103
  • [2] Biomarkers of neuroprogression and late staging in bipolar disorder: A systematic review
    Grewal, Sonya
    McKinlay, Stuart
    Kapczinski, Flavio
    Pfaffenseller, Bianca
    Wollenhaupt-Aguiar, Bianca
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2023, 57 (03): : 328 - 343
  • [3] Evidence-based treatment strategies for rapid cycling bipolar disorder, a systematic review
    Roosen, L.
    Sienaert, P.
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 311 : 69 - 77
  • [4] Biomarkers of bipolar disorder based on metabolomics: A systematic review
    Chen, Jin
    Amdanee, Nousayhah
    Zuo, Xiaowei
    Wang, Yu
    Gong, Muxin
    Yang, Yujing
    Li, Hao
    Zhang, Xiangrong
    Zhang, Caiyi
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 350 : 492 - 503
  • [5] A review of evidence-based psychosocial interventions for bipolar disorder
    Miklowitz, David J.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 : 28 - 33
  • [6] Bipolar disorder in late life: A review
    Chen, ST
    Altshuler, LL
    Spar, JE
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 1998, 11 (01) : 29 - 35
  • [7] Myth of evidence-based medicine for bipolar disorder
    Post, Robert M.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (09) : 1271 - 1273
  • [8] Commentary: Evidence-based pharmacotherapy of bipolar disorder
    Ghaemi, SN
    Soldani, F
    Hsu, DJ
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2003, 6 (03): : 303 - 308
  • [9] CINP evidence-based guidelines for bipolar disorder
    Yatham, L.
    Milev, R.
    Vieta, E.
    Young, A.
    Schaffer, A.
    BIPOLAR DISORDERS, 2017, 19 : 18 - 18
  • [10] Systematic, evidence-based discovery of biomarkers at the NCI
    John R. Prensner
    Arul M. Chinnaiyan
    Sudhir Srivastava
    Clinical & Experimental Metastasis, 2012, 29 : 645 - 652